Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Covid-19; Covid-19; This is a spontaneous report from a non-contactable physician from the regulatory authority-WEB DE-PEI-PEI2021003038 . A 80-year-old female patient received two doses bnt162b2 (COMIRNATY) , via an unspecified route of administration on 04Jan2021 and 25Jan2021 both at single doses for covid-19 immunisation. Medical history included myositis. Concomitant medication included immunotherapy with mycophenolate mofetil (CELLCEPT) for myositis. On 12Feb2021 after vaccination the patient developed COVID-19 and death on 12Feb2021. Diagnosis was confirmed by COVID-19 PCR test (result: positive) in Feb2021. Death cause was reported as COVID-19. The patient died on 12Feb2021. An autopsy was not performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: COVID-19; COVID-19
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166